175 related articles for article (PubMed ID: 38114489)
21. Perspective: Extending the Utility of Three-Dimensional Organoids by Tissue Clearing Technologies.
Susaki EA; Takasato M
Front Cell Dev Biol; 2021; 9():679226. PubMed ID: 34195197
[TBL] [Abstract][Full Text] [Related]
22. Methodological aspects and pharmacological applications of three-dimensional cancer cell cultures and organoids.
Foglietta F; Canaparo R; Muccioli G; Terreno E; Serpe L
Life Sci; 2020 Aug; 254():117784. PubMed ID: 32416169
[TBL] [Abstract][Full Text] [Related]
23. Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma.
Sundar SJ; Shakya S; Barnett A; Wallace LC; Jeon H; Sloan A; Recinos V; Hubert CG
Transl Oncol; 2022 Jan; 15(1):101251. PubMed ID: 34700192
[TBL] [Abstract][Full Text] [Related]
24. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
25. Metabolomics-based mass spectrometry methods to analyze the chemical content of 3D organoid models.
Murphy SE; Sweedler JV
Analyst; 2022 Jun; 147(13):2918-2929. PubMed ID: 35660810
[TBL] [Abstract][Full Text] [Related]
26. OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening.
Deben C; De La Hoz EC; Compte ML; Van Schil P; Hendriks JMH; Lauwers P; Yogeswaran SK; Lardon F; Pauwels P; Van Laere S; Bogaerts A; Smits E; Vanlanduit S; Lin A
Cell Oncol (Dordr); 2023 Apr; 46(2):299-314. PubMed ID: 36508089
[TBL] [Abstract][Full Text] [Related]
27. The CellRaft AIR
Stern A; Thompson B; Williams K; McClellan R; Gebhart S; Hartman J
SLAS Discov; 2022 Apr; 27(3):201-208. PubMed ID: 35058186
[TBL] [Abstract][Full Text] [Related]
28. Self-assembly of three-dimensional liver organoids: virtual reconstruction
Zhang Z; Wu Y; Xuan Z; Xu H; Yin S; Meng Z
Biomater Sci; 2023 Dec; 11(24):7867-7883. PubMed ID: 37902572
[No Abstract] [Full Text] [Related]
29. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
30. Multiscale Analysis of Cellular Composition and Morphology in Intact Cerebral Organoids.
Ma H; Chen J; Deng Z; Sun T; Luo Q; Gong H; Li X; Long B
Biology (Basel); 2022 Aug; 11(9):. PubMed ID: 36138749
[TBL] [Abstract][Full Text] [Related]
31. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
32. Non-Invasive Label-free Analysis Pipeline for In Situ Characterization of Differentiation in 3D Brain Organoid Models.
Filan C; Charles S; Casteleiro Costa P; Niu W; Cheng BF; Wen Z; Lu H; Robles FE
Res Sq; 2024 Apr; ():. PubMed ID: 38645145
[TBL] [Abstract][Full Text] [Related]
33. The drug-induced phenotypic landscape of colorectal cancer organoids.
Betge J; Rindtorff N; Sauer J; Rauscher B; Dingert C; Gaitantzi H; Herweck F; Srour-Mhanna K; Miersch T; Valentini E; Boonekamp KE; Hauber V; Gutting T; Frank L; Belle S; Gaiser T; Buchholz I; Jesenofsky R; Härtel N; Zhan T; Fischer B; Breitkopf-Heinlein K; Burgermeister E; Ebert MP; Boutros M
Nat Commun; 2022 Jun; 13(1):3135. PubMed ID: 35668108
[TBL] [Abstract][Full Text] [Related]
34. Organoids revealed: morphological analysis of the profound next generation in-vitro model with artificial intelligence.
Du X; Chen Z; Li Q; Yang S; Jiang L; Yang Y; Li Y; Gu Z
Biodes Manuf; 2023; 6(3):319-339. PubMed ID: 36713614
[TBL] [Abstract][Full Text] [Related]
35. An AI-based segmentation and analysis pipeline for high-field MR monitoring of cerebral organoids.
Deininger L; Jung-Klawitter S; Mikut R; Richter P; Fischer M; Karimian-Jazi K; Breckwoldt MO; Bendszus M; Heiland S; Kleesiek J; Opladen T; Kuseyri Hübschmann O; Hübschmann D; Schwarz D
Sci Rep; 2023 Dec; 13(1):21231. PubMed ID: 38040865
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in organoid engineering: A comprehensive review.
Unagolla JM; Jayasuriya AC
Appl Mater Today; 2022 Dec; 29():. PubMed ID: 38264423
[TBL] [Abstract][Full Text] [Related]
37. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
[TBL] [Abstract][Full Text] [Related]
38. Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing.
Van Hemelryk A; Mout L; Erkens-Schulze S; French PJ; van Weerden WM; van Royen ME
Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827570
[TBL] [Abstract][Full Text] [Related]
39. OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics.
Matthews JM; Schuster B; Kashaf SS; Liu P; Ben-Yishay R; Ishay-Ronen D; Izumchenko E; Shen L; Weber CR; Bielski M; Kupfer SS; Bilgic M; Rzhetsky A; Tay S
PLoS Comput Biol; 2022 Nov; 18(11):e1010584. PubMed ID: 36350878
[TBL] [Abstract][Full Text] [Related]
40. D-CryptO: deep learning-based analysis of colon organoid morphology from brightfield images.
Abdul L; Xu J; Sotra A; Chaudary A; Gao J; Rajasekar S; Anvari N; Mahyar H; Zhang B
Lab Chip; 2022 Oct; 22(21):4118-4128. PubMed ID: 36200406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
